NPPA issued a notification regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 500mg

Mar 01, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 01, 2024, issued a notification regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 500mg.

The following has been stated: -

•Each film-coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 500mg the Retail Price (without local taxes) is 15.11.

[Notification No. 19(3874)/2024/DP/NPPA/Div.III/7641/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT